Avid Bioservices Inc (CDMO)

[md1225]

Some clarity?

1) melanoma trial started 10/13 PRd on 4/14 I believe the company stated was open label and investors would be updated throughout the trial? I don't remember an update?

2) funding the next two late stage trials? MSK? partner? PPHMP?

3) dilution... why did the company dilute another 6 million shares of common stock over the past quarter? Why did the company not do another PPHMP placement to stop further dilution of common stock?

4)will the company update investors of the first look-in? I believe it has passed. Is "it" and melanoma data held close to vest for partnering reasons?

5) I would like to attend the Boston conference could the company arrange admittance for myself and one associate.